AF Association News & Events
Atrial Fibrillation Association won a Commended Award for our AF and You Booklet
Should We Switch Patients Who Appear to Be Optimally Anticoagulated on Warfarin to DOACs?*
wo different types of oral anticoagulants (OACs) are currently available to reduce the risk of stroke/systemic embolism (SE) in patients with atrial fibrillation (AF): vitamin K antagonists (VKAs) and direct OACs (DOACs) (1).
2018 Healthcare and Cardiology Conference
Free stroke prevention tests to be held across the borough this week
A CUTTING-edge stroke prevention test will be available for free on the St Helens streets this week at a series of events held across the borough.
Stroke prevention in Europe: how are 11 European countries progressing toward the European Society of Cardiology (ESC) recommendations?
Stroke is a leading cause of death and disability, although studies show that 90% of strokes can be prevented.
September Medical e-News 2018
BREAKING NEWS-Arrhythmia Alliance Grants to attend HRC2018 and much more.
Arrhythmia Alliance Educates people on the Risks of Heart Rhythm Disorders for World Heart Day 2018
World Heart Day is a global campaign to raise awareness of heart health, Arrhythmia Alliance is urging everyone to Know Your Pulse to know your heart rhythm. The aim is to educate people about the risk factors relating to the heart, which can result in premature deaths from heart disease and stroke.
New Apple Watch OK'd for Arrhythmia Detection
The latest iteration of the Apple Watch, dubbed Series 4, was released Wednesday and with it came FDA clearance for use in detection and notification of atrial fibrillation and other arrhythmias.
September Patient e-News 2018
We Need You! Find out all the latest here.
Improve the care of people living with AF Patient Survey
We want to improve the care of people living with AF. This short survey, sponsored by a pharmaceutical company, is for people who are taking an anti-coagulant therapy to prevent an AF-related stroke. The outputs of this research will be used for information only by the sponsoring pharmaceutical company and no confidential information will be passed on to them.